Global Healthcare Focus OrbiMed operates across the global healthcare landscape from startups to multinationals, presenting opportunities to partner on private equity, public equity, and royalty/credit financing across diverse segments such as biotech, medtech, and healthcare services.

Large Funded Growth With a revenue scale of one to ten billion and a portfolio strategy spanning private equity and growth investments, OrbiMed seeks tailored financing solutions, signaling receptiveness to scalable capital arrangements and growth-stage rounds.

Active Investment Activity Recent high-profile investments in Entero Healthcare, Slate Medicines, Iswarya Fertility, TruNativ, and Windward Bio indicate a continued appetite for growth rounds, cross-border deals, and strategic partnerships in specialty areas.

Global Team Access OrbiMed has a broad geographic footprint with professionals in New York, San Francisco, Shanghai, Hong Kong, Mumbai, and Herzliya, enabling multi-market deal sourcing, due diligence, and post-investment support.

Tech and Innovation Alignment Their technology stack and use of AI tools, combined with diversified fund offerings, suggest opportunities to offer digital health analytics, AI-enabled clinical development solutions, or platform enhancements that align with OrbiMed’s portfolio companies.